2 Reasons Regeneron Stock Could Crush the Market for the Next 10 Years

2 Reasons Regeneron Stock Could Crush the Market for the Next 10 Years

Key PointsRegeneron's main growth driver should perform well through the end of the decade.The biotech should launch newer medicines in the coming years. 10 stocks we like better than Regeneron Pharmaceuticals › Healthcare stocks have underperformed broader equities in recent years. But plenty of companies in the sector still look like good long-term bets. Take Regeneron Pharmaceuticals (NASDAQ: REGN), a biotech leader. Although it's faced its s…